Spero Therapeutics, Inc.·4

Nov 15, 4:17 PM ET

Rajavelu Esther 4

4 · Spero Therapeutics, Inc. · Filed Nov 15, 2023

Insider Transaction Report

Form 4
Period: 2023-11-13
Rajavelu Esther
See Remarks
Transactions
  • Award

    Common Stock

    2023-11-13+300,000300,000 total
Footnotes (1)
  • [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on November 6, 2024, subject to the Reporting Person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4